MedTrace Logo

Mother-to-child Transmission of HBV in China

NCT05172453 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50000

Last updated 2021-12-29

No results posted yet for this study

Summary

In order to evaluate the feasibility of eliminating mother-to-child transmission (MTCT) of hepatitis B virus (HBV) by 2030, a multi-center, prospective cohorts study was conducted to investigate MTCT of HBV in China.

Conditions

  • Hepatitis B, Chronic
  • Mother to Child Transmission

Interventions

OTHER

comprehensive management algorithm for preventing mother-to-child transmission of HBV

To standardize the clinical management of preventing MTCT of HBV and reduce incidences of MTCT, the Chinese Foundation for Hepatitis Prevention and Control (CFHPC) organized experts to compile the "Management algorithm for prevention of mother-to-child transmission of hepatitis B virus" based on the latest research progress and recently published guidelines, which includes 10 steps of pregnancy management and postpartum follow-up, among which screening, antiviral treatment, and infant immunization are its core contents.

Sponsors & Collaborators

  • Chinese Foundation for Hepatitis Prevention and Control

    collaborator UNKNOWN

  • Tigermed Consulting Co., Ltd

    collaborator INDUSTRY

  • Nanfang Hospital, Southern Medical University

    lead OTHER

Principal Investigators

  • Jinlin Hou · Nanfang Hospital, Southern Medical University

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-01
Primary Completion
2025-06-30
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05172453 on ClinicalTrials.gov